COMPASS Pathways Aktie
WKN DE: A2QCDR / ISIN: US20451W1018
|
20.04.2026 18:02:35
|
Why Compass Pathways Stock Rocketed 40% Today
A White House Executive Order over the weekend has some healthcare company stocks soaring today. One big winner is Compass Pathways (NASDAQ: CMPS). Shares of the biotechnology company rocketed more than 50% this morning and were still higher by 41.2% at noon ET. Compass is a leader in the development of a new approach to mental health treatment, concentrating on achieving results through the creation of a synthetic psilocybin therapy. Psilocybin is a naturally occurring psychedelic compound found in certain types of mushrooms, commonly referred to as "magic mushrooms."Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu COMPASS Pathways PLC (spons. ADRs)
|
03.11.25 |
Ausblick: COMPASS Pathways zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu COMPASS Pathways PLC (spons. ADRs)
Aktien in diesem Artikel
| COMPASS Pathways PLC (spons. ADRs) | 7,40 | 30,97% |
|